Your browser is no longer supported. Please, upgrade your browser.
AMRN Amarin Corporation plc weekly Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.31 Insider Own0.50% Shs Outstand274.08M Perf Week-4.60%
Market Cap909.95M Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float149.51M Perf Month-1.48%
Income-77.80M PEG- EPS next Q-0.05 Inst Own38.40% Short Float4.97% Perf Quarter-22.43%
Sales151.30M P/S6.01 EPS this Y50.60% Inst Trans0.21% Short Ratio4.05 Perf Half Y5.06%
Book/sh-0.23 P/B- EPS next Y71.40% ROA-44.10% Target Price7.60 Perf Year12.16%
Cash/sh0.31 P/C10.64 EPS next 5Y9.00% ROE195.90% 52W Range2.75 - 4.47 Perf YTD7.79%
Dividend- P/FCF- EPS past 5Y5.10% ROI-91.10% 52W High-25.73% Beta0.65
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin74.80% 52W Low20.73% ATR0.12
Employees215 Current Ratio1.70 Sales Q/Q36.60% Oper. Margin-38.50% RSI (14)47.39 Volatility3.03% 3.49%
OptionableYes Debt/Eq- EPS Q/Q30.40% Profit Margin-51.40% Rel Volume0.48 Prev Close3.32
ShortableYes LT Debt/Eq- EarningsNov 02 BMO Payout- Avg Volume1.83M Price3.32
Recom1.60 SMA20-2.88% SMA500.99% SMA2001.11% Volume0 Change0.00%
Jun-27-17Resumed Cantor Fitzgerald Overweight
Oct-19-16Initiated Citigroup Buy $5
Oct-05-16Initiated Cantor Fitzgerald Buy $6
May-12-16Resumed Jefferies Buy
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Oct-10-17 10:58AM  ETFs with exposure to Amarin Corp. Plc : October 10, 2017 Capital Cube
Sep-28-17 10:09AM  ETFs with exposure to Amarin Corp. Plc : September 28, 2017 Capital Cube
Sep-25-17 06:00AM  Amarin and HLS Therapeutics Announce Agreement to Commercialize Vascepa® in Canada GlobeNewswire
Sep-20-17 04:30PM  Amarin to Present at Cantor Global Healthcare Conference GlobeNewswire
Sep-13-17 06:00AM  Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer GlobeNewswire
Sep-11-17 08:20PM  ETFs with exposure to Amarin Corp. Plc : September 12, 2017 Capital Cube
Sep-06-17 06:00AM  Amarin to Present at Rodman & Renshaws Global Investment Conference GlobeNewswire
Aug-31-17 05:12PM  ETFs with exposure to Amarin Corp. Plc : August 31, 2017 Capital Cube
Aug-25-17 10:45AM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
Aug-14-17 07:10AM  Featured Company News GlaxoSmithKline Drops Options to Licence Inotersen and IONIS-FB-LRx; Ionis Pharma to Continue Development Independently ACCESSWIRE
06:00AM  Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee GlobeNewswire
Aug-12-17 01:15AM  Edited Transcript of AMRN earnings conference call or presentation 2-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-04-17 08:58AM  Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock? Zacks
Aug-02-17 10:55PM  Amarin reports 2Q loss Associated Press
12:32PM  Here's Why Amarin Corporation plc Is on the Rise Today Motley Fool
06:00AM  Investor Network: Amarin Corporation Plc to Host Earnings Call ACCESSWIRE
05:30AM  Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations GlobeNewswire
Aug-01-17 04:05PM  Investor Calendar Invites You to the Amarin Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017 ACCESSWIRE
Jul-26-17 04:30PM  Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 GlobeNewswire
Jul-10-17 01:29PM  Here's Why Amarin Corporation plc Surged 34% Higher in June Motley Fool
Jun-28-17 08:42AM  Is the Options Market Predicting a Spike in Amarin (AMRN) Stock? Zacks +8.31%
08:00AM  Today's Research Reports on Stocks to Watch: OraSure Technologies and Amarin Corporation Accesswire
Jun-27-17 02:51PM  ETFs with exposure to Amarin Corp. Plc : June 27, 2017 Capital Cube
Jun-26-17 05:01PM  Cantor Pounds The Table On Amarin Corporation plc (ADR) (AMRN) SmarterAnalyst
01:08PM  3 Cheap Healthcare Stocks You Can Buy Right Now Motley Fool
Jun-13-17 09:29AM  Opening Bell, June 13, 2017 CNBC Videos
09:15AM  Today's Bell Ringer, June 13, 2017 CNBC Videos
Jun-12-17 10:00AM  Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
07:00AM  Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides GlobeNewswire
Jun-02-17 01:50PM  ETFs with exposure to Amarin Corp. Plc : June 2, 2017 Capital Cube
Jun-01-17 06:00AM  Amarin to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-24-17 03:46PM  3 Healthcare Stocks for Savvy Investors Motley Fool
May-22-17 01:20PM  ETFs with exposure to Amarin Corp. Plc : May 22, 2017 Capital Cube
May-18-17 06:00AM  Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care GlobeNewswire
May-11-17 04:06PM  ETFs with exposure to Amarin Corp. Plc : May 11, 2017 Capital Cube
May-10-17 11:27AM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-08-17 08:42AM  Is the Options Market Predicting a Spike in Amarin Corporation (AMRN) Stock? Zacks
07:41AM  Edited Transcript of AMRN earnings conference call or presentation 3-May-17 12:00pm GMT Thomson Reuters StreetEvents
May-03-17 07:05AM  Investor Network: Amarin Corporation Plc Sponsored ADR to Host Earnings Call Accesswire -5.05%
05:06AM  Amarin reports 1Q loss Associated Press
05:00AM  Amarin Reports First Quarter 2017 Financial Results and Provides Update on Operations GlobeNewswire
May-02-17 04:05PM  Investor Calendar Invites You to the Amarin First Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, May 3, 2017 Accesswire
Apr-26-17 03:04PM  ETFs with exposure to Amarin Corp. Plc : April 26, 2017 Capital Cube
Apr-25-17 04:30PM  Amarin to Report First Quarter 2017 Results and Host Conference Call on May 3, 2017 GlobeNewswire
Apr-20-17 09:40AM  Overseas Earnings Estimated to Outdo US: Top 5 Gainers Zacks
Apr-07-17 03:46PM  ETFs with exposure to Amarin Corp. Plc : April 7, 2017 Capital Cube
10:24AM  3 Stocks the Smartest Investors Are Buying Right Now Motley Fool
Mar-28-17 12:24PM  3 Stocks That Could Make You Rich Motley Fool
12:24PM  3 Stocks That Could Make You Rich at Motley Fool
Mar-27-17 04:18PM  AMARIN CORP PLC\UK Files SEC form 8-K, Shareholder Director Nominations
Mar-21-17 08:09AM  4 Biotech Stocks With Jaw-Dropping Growth Potential Motley Fool -5.09%
08:09AM  4 Biotech Stocks With Jaw-Dropping Growth Potential at Motley Fool
08:00AM  Amarin Corporation CEO, John Thero, to Chair the American Heart Associations Heart & Stroke Ball in New York City GlobeNewswire
Mar-16-17 05:00AM  Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study GlobeNewswire
Mar-15-17 09:56AM  Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology GlobeNewswire
Mar-08-17 01:04PM  AMARIN CORP PLC\UK Financials
Mar-07-17 12:22PM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Capital Cube
12:22PM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
Mar-06-17 11:22AM  Here's What Pushed Amarin Corporation plc 15% Higher in February Motley Fool
11:22AM  Here's What Pushed Amarin Corporation plc 15% Higher in February at Motley Fool
Mar-01-17 05:12PM  AMARIN CORP PLC\UK Files SEC form 10-K, Annual Report
Feb-28-17 09:22AM  Biotech Premarket Movers: Cempra, Novavax, Ionis
07:07AM  Q4 2016 Amarin Corporation PLC Earnings Release - Before Market Open
06:31AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
06:21AM  Amarin reports 4Q loss Associated Press
06:00AM  Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations GlobeNewswire
Feb-23-17 10:07AM  Why President Trump Wants To Transform The FDA And What It Could Mean For Biotech Stocks at Insider Monkey
Feb-22-17 08:00AM  Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017 GlobeNewswire
Feb-09-17 07:50AM  Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-25-17 04:05PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl
Jan-20-17 07:19AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
06:00AM  Amarin Announces Debt Restructuring and Related Private Placement of Exchangeable Senior Notes GlobeNewswire
Jan-18-17 06:46PM  FDA issues draft guidance to better medical product labeling Reuters
12:33PM  FDA proposes off-label communication norms for medical products Reuters
Jan-12-17 10:09AM  More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017 at Motley Fool
Jan-10-17 09:39AM  1 Reason Amarin's Stock Skyrocketed in 2016 at Motley Fool
Jan-05-17 04:47PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Amarin Provides Preliminary 2016 Results and 2017 Outlook GlobeNewswire
Dec-27-16 12:19PM  ETFs with exposure to Amarin Corp. Plc : December 27, 2016
Dec-21-16 09:30AM  Zacks.com featured highlights: Amarin, Two Harbors Investment, Fairmount Santrol Holdings, Vale and Oclaro
Dec-20-16 03:31PM  Explosive Stocks Under $10
Dec-16-16 04:31PM  Amarin Announces Contractual Reminder of Optional Put to Holders of $15.1 million Principal Amount of Outstanding 3.50% Exchangeable Senior Notes Due 2032 GlobeNewswire
04:09PM  AMARIN CORP PLC\UK Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Dec-13-16 02:05PM  Is CytomX Therapeutics Inc (CTMX) A Good Stock To Buy? at Insider Monkey
12:24PM  ETFs with exposure to Amarin Corp. Plc : December 13, 2016
Dec-11-16 08:46AM  Is Loxo Oncology Inc (LOXO) Worthy of Your Portfolio? at Insider Monkey
Dec-10-16 10:07AM  Is Modine Manufacturing Co. (MOD) A Good Stock To Buy? at Insider Monkey
Dec-08-16 07:14AM  Do Hedge Funds Love Amarin Corporation plc (ADR) (AMRN)? at Insider Monkey
Dec-05-16 11:24AM  Why Amarin (AMRN) Could Beat Earnings Estimates Again
Dec-02-16 08:37AM  Amarin (AMRN): Strong Industry, Solid Earnings Estimate Revisions
Nov-29-16 03:03PM  ETFs with exposure to Amarin Corp. Plc : November 29, 2016
Nov-24-16 05:48PM  The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 at Insider Monkey
Nov-20-16 07:26AM  Penny Stocks: 2 to Buy, 2 to Avoid at Motley Fool
Nov-18-16 09:55AM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 09:25AM  Patterson Companies (PDCO) Q2 Earnings: What's in Store?
09:14AM  Can Veeva Systems (VEEV) Pull a Surprise in Q3 Earnings?
Nov-14-16 07:30PM  Pure EPA Vascepa® (icosapent ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Parameters in Statin-Treated Women with Persistent High Triglycerides GlobeNewswire
Nov-11-16 10:27AM  Amarin to Present at the Jefferies 2016 London Healthcare Conference GlobeNewswire
Nov-09-16 08:52AM  Amarin's Stock Buckled in October. Is It Now a Bargain? at Motley Fool +6.51%
Nov-03-16 11:11AM  3 Important Things You Need to Know About Amarin's Q3 Results at Motley Fool -11.29%
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. Amarin Corporation plc sells its product principally to wholesalers and specialty pharmacy providers. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.